10-K/A XBRL

AMENDMENT NO. 1 TO FORM 10-K

Company: Raphael Pharmaceutical Inc.
Filed: May 25, 2023
Period of Report: December 31, 2022
Accession Number: 0001213900-23-043104

View Document ↗ View on SEC.gov ↗